Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Microbiome Sequencing Market: By Technology, Sequencing by Ligation, Targeted Gene Sequencing Others), By Application, By Research Type, By End User and Geography
Microbiome Sequencing Market was valued at US$ 1.71 billion in 2023 and is poised to grow at a 6.7% CAGR from 2024- 2030. The market for microbiome sequencing services is expanding due in large part to the rising demand for Next-Generation Sequencing. For example, next-generation sequencing (NGS) technology has advanced our understanding of the human microbiome by enabling the discovery and characterization of unculturable microbes with function predictions, according to a paper published in the Journal of Clinical Investigation in April 2022. The market for next-generation sequencing services is anticipated to increase at a faster rate because of these innovations. The market for microbiome sequencing services is expected to develop over the forecast period due in part to the global upsurge in genomic research. For example, data on genomic data science updated in April 2022 by the National Human Genome Research Institute of the United States National Institute of Health showed that the amount of genomic data generated is growing annually, ranging from 2 to 40 billion gigabytes, in tandem with the rapid expansion of large-scale collaborations and biomedical research projects.
The market for microbiome sequencing services is expanding because of numerous genomic research R&D initiatives. Additionally, the spike in gut research based on genomics and the increasing demand for Next-generation Sequencing (NGS) are the main factors driving the market expansion. All the bacteria, fungi, viruses, and protists that are present in and on the human body as well as in the environment are collectively referred to as the microbiome. Researchers are employing metagenomics sequencing, which involves the continuous sequencing of genetic information from many organisms, to identify the bacteria that comprise a certain microbiome. Therefore, it is anticipated that the previously mentioned elements—such as the expansion of genomic research, advancements in NGS technology, and the growing innovations made by industry participants—will spur market expansion. The shortage of qualified specialists for NGS data analysis and ethical and legal concerns surrounding genome sequencing, however, are impeding the market's expansion for microbiome sequencing services throughout the projected timeframe.
Study Period
2024 - 2030Base Year
2023CAGR
6.7%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The growth and innovation of the pharmaceutical industry to launch microbiome sequencing services due to the huge health-conscious consumers is creating an opportunity for the microbiome sequencing market. Microbiome sequencing market growth is expected to be supported by emerging markets due to the availability of improved healthcare infrastructure, increasing unmet healthcare needs, increasing prevalence of chronic diseases in adults, and growing demand for next-generation sequencing technology. Market growth of Microbiome Sequencing is driven by increase in the number of R&D institutions in the biological field due to genomic research and the prevalence of chronic diseases. The factor is expected to drive the growth of the market are the increasing demand due to the expansion of next generation sequencing for microbiome sequencing services, its implementation and reduction of sequencing costs. Surge in awareness and benefits of microbiome sequencing in cancer treatment is expected to fuel the market. For example, according to an article published in the journal BMC 2021, microbiome sequencing has been used to understand tissue microbiome composition and has been useful in predicting colorectal cancer prognosis using 16S rRNA amplicon sequencing. In addition, the increased use of the human microbiome for drug development and the use of sequencing technologies for the development of personalized medicine are expected to stimulate the growth of the microbiome sequencing market.
Rising prevalence of chronic diseases will significantly affect the microbiome sequencing market forecast. Various organizations, including the government, advise people about microbiome sequencing applications. Factors such as increased adoption of microbiome sequencing and growing awareness about the use of sequencing are driving the growth of the market. In addition, increased promotional efforts by manufacturers, increased awareness of the microbiome, and increased demand for next-generation sequencing of the population are expected to drive their adoption in the near future. However, factor such as lack of skilled personnel in operating system is limiting the growth of microbiome sequencing market. Additionally, stringent regulations and government regulations on microbiome sequencing may also hamper the market growth. Conversely, advances in the development of efficient sequencing services and the need for next-generation sequencing technology provide lucrative opportunities for market players.
Report Benchmarks |
Details |
Report Study Period |
2024 - 2030 |
Market Size in 2023 |
US$ 1.71 billion |
Market CAGR |
6.7% |
By Technology |
|
By Application |
|
By End User |
|
Download Free Sample Report
The Microbiome sequencing Market was valued at US$ 1.71 billion in 2023 and is poised to grow at a CAGR of 6.7 %.
Microbiome sequencing key factors driving market growth include increased genomic research and microbiome sequencing applications, as well as rapid adoption of NGS in emerging economies.
The future trends in the market are the use of microbiome sequencing in the early diagnosis of diseases and the use of this technology in the development of individualized medicines for various diseases.
RNA sequencing is the leading technology in the microbiome sequencing market.
Market research is segmented based on technology, application , end user and region.
Asain-Pacific is expected to fastest-growing region in the Microbiome sequencing Market.
1. Executive Summary |
2. Global Microbiome Sequencing Market Introduction |
2.1. Global Microbiome Sequencing Market – Taxonomy |
2.2. Global Microbiome Sequencing Market –Definitions |
2.2.1. Technology |
2.2.2. Application |
2.2.3. Research Type |
2.2.4. End User |
3. Global Microbiome Sequencing Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Microbiome Sequencing Market Dynamic Factors - Impact Analysis |
3.6. Global Microbiome Sequencing Market – Competition Landscape |
4. Global Microbiome Sequencing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Microbiome Sequencing Market, By Technology, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.1. Shotgun Sequencing |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Sequencing by Synthesis (SBS) |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Sequencing by Ligation (SBL) |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Targeted Gene Sequencing |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Others |
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
6. Global Microbiome Sequencing Market, By Application, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.1. Gastrointestinal Diseases |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Infectious Diseases |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. CNS Diseases |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Oncology |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Other |
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
7. Global Microbiome Sequencing Market, By Research Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.1. Outsourced Research |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Internal Research |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
8. Global Microbiome Sequencing Market, By End User Industry, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.1. Pharmaceutical and Biotechnology Companies |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Academia/Research Institutes |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Contract Research organizations |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
9. Global Microbiome Sequencing Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.1. North America |
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia-Pacific |
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Latin America |
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Middle East and Africa |
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
9.6. Global Microbiome Sequencing Market - Opportunity Analysis Index, By Technology, By Application, By Research Type, By End User Industry, and Region, 2024 - 2030 |
10. North America Microbiome Sequencing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
10.1. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Shotgun Sequencing |
10.1.2. Sequencing by Synthesis (SBS) |
10.1.3. Sequencing by Ligation (SBL) |
10.1.4. Targeted Gene Sequencing |
10.1.5. Others |
10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.2.1. Gastrointestinal Diseases |
10.2.2. Infectious Diseases |
10.2.3. CNS Diseases |
10.2.4. Oncology |
10.2.5. Other |
10.3. Research Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Outsourced Research |
10.3.2. Internal Research |
10.4. End User Industry Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.4.1. Pharmaceutical and Biotechnology Companies |
10.4.2. Academia/Research Institutes |
10.4.3. Contract Research organizations |
10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.5.1. USA |
10.5.2. Canada |
10.6. North America Microbiome Sequencing Market - Opportunity Analysis Index, By Technology, By Application, By Research Type, By End User Industry, and Country, 2024 - 2030 |
10.7. North America Microbiome Sequencing Market Dynamics – Trends |
11. Europe Microbiome Sequencing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
11.1. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Shotgun Sequencing |
11.1.2. Sequencing by Synthesis (SBS) |
11.1.3. Sequencing by Ligation (SBL) |
11.1.4. Targeted Gene Sequencing |
11.1.5. Others |
11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.2.1. Gastrointestinal Diseases |
11.2.2. Infectious Diseases |
11.2.3. CNS Diseases |
11.2.4. Oncology |
11.2.5. Other |
11.3. Research Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Outsourced Research |
11.3.2. Internal Research |
11.4. End User Industry Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.4.1. Pharmaceutical and Biotechnology Companies |
11.4.2. Academia/Research Institutes |
11.4.3. Contract Research organizations |
11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.5.1. Germany |
11.5.2. UK |
11.5.3. France |
11.5.4. Spain |
11.5.5. Italy |
11.5.6. Rest of Europe |
11.6. Europe Microbiome Sequencing Market - Opportunity Analysis Index, By Technology, By Application, By Research Type, By End User Industry, and Country, 2024 - 2030 |
11.7. Europe Microbiome Sequencing Market Dynamics – Trends |
12. Asia-Pacific Microbiome Sequencing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
12.1. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Shotgun Sequencing |
12.1.2. Sequencing by Synthesis (SBS) |
12.1.3. Sequencing by Ligation (SBL) |
12.1.4. Targeted Gene Sequencing |
12.1.5. Others |
12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.2.1. Gastrointestinal Diseases |
12.2.2. Infectious Diseases |
12.2.3. CNS Diseases |
12.2.4. Oncology |
12.2.5. Other |
12.3. Research Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Outsourced Research |
12.3.2. Internal Research |
12.4. End User Industry Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Pharmaceutical and Biotechnology Companies |
12.4.2. Academia/Research Institutes |
12.4.3. Contract Research organizations |
12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.5.1. China |
12.5.2. India |
12.5.3. Japan |
12.5.4. ASEAN |
12.5.5. Australia & New Zealand |
12.5.6. Rest of Asia-Pacific |
12.6. Asia-Pacific Microbiome Sequencing Market - Opportunity Analysis Index, By Technology, By Application, By Research Type, By End User Industry, and Country, 2024 - 2030 |
12.7. Asia-Pacific Microbiome Sequencing Market Dynamics – Trends |
13. Latin America Microbiome Sequencing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
13.1. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Shotgun Sequencing |
13.1.2. Sequencing by Synthesis (SBS) |
13.1.3. Sequencing by Ligation (SBL) |
13.1.4. Targeted Gene Sequencing |
13.1.5. Others |
13.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.2.1. Gastrointestinal Diseases |
13.2.2. Infectious Diseases |
13.2.3. CNS Diseases |
13.2.4. Oncology |
13.2.5. Other |
13.3. Research Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.3.1. Outsourced Research |
13.3.2. Internal Research |
13.4. End User Industry Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.4.1. Pharmaceutical and Biotechnology Companies |
13.4.2. Academia/Research Institutes |
13.4.3. Contract Research organizations |
13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
13.5.1. Brazil |
13.5.2. Mexico |
13.5.3. Rest of Latin America |
13.6. Latin America Microbiome Sequencing Market - Opportunity Analysis Index, By Technology, By Application, By Research Type, By End User Industry, and Country, 2024 - 2030 |
13.7. Latin America Microbiome Sequencing Market Dynamics – Trends |
14. Middle East and Africa Microbiome Sequencing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
14.1. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.1.1. Shotgun Sequencing |
14.1.2. Sequencing by Synthesis (SBS) |
14.1.3. Sequencing by Ligation (SBL) |
14.1.4. Targeted Gene Sequencing |
14.1.5. Others |
14.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.2.1. Gastrointestinal Diseases |
14.2.2. Infectious Diseases |
14.2.3. CNS Diseases |
14.2.4. Oncology |
14.2.5. Other |
14.3. Research Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.3.1. Outsourced Research |
14.3.2. Internal Research |
14.4. End User Industry Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.4.1. Pharmaceutical and Biotechnology Companies |
14.4.2. Academia/Research Institutes |
14.4.3. Contract Research organizations |
14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
14.5.1. Gulf Cooperation Council (GCC) Countries |
14.5.2. South Africa |
14.5.3. Rest of MEA |
14.6. MEA Microbiome Sequencing Market - Opportunity Analysis Index, By Technology, By Application, By Research Type, By End User Industry, and Country, 2024 - 2030 |
14.7. MEA Microbiome Sequencing Market Dynamics – Trends |
15. Competition Landscape |
15.1. Strategic Dashboard of Top Market Players |
15.2. Company Profiles (Introduction, Financial Analysis, Key Technologies, Key Developments, Strategies, and SWOT Analysis) |
15.2.1. Baseclear BV |
15.2.2. Clinical Microbiomics AS |
15.2.3. Merieux Nutrisciences Corporations |
15.2.4. EPIBIOME |
15.2.5. Microbiome Insights Inc |
15.2.6. Microbiome Therapeutics LLC |
15.2.7. MR DNA |
15.2.8. Second Genome |
15.2.9. Ubiome Inc. |
15.2.10. Clear Labs |
16. Research Methodology |
17. Key Assumptions and Acronyms |
Key Market Players